Invitation:

Riding the horse year into 2014, we are anticipating a special and successful year! On the wave of this special time, we are preparing for our SABPA 9th Annual Biomedical Forum on Saturday, April 26th, 2014 in Crowne Plaza Hotel in Costa Mesa, CA. The Annual Biomedical Forum is the flagship event of our SABPA OC/LA chapter. It gathers elite speakers from academics, industries, IP law experts, and investors from both the United States and China. The topics will cover a broad range of subjects, including drug discovery, diagnostics, micro implants for eyes, cardiovascular medical devices, personalized medicine, bio-3D printing, IP protection, and medical devices in China. We are very excited about this year’s program and expect a highly successful event.

We sincerely invite you all to join this forum and take this opportunity to learn, share, and network among our scientists, engineers, investors, executives, students, entrepreneurs, and policy makers in order to promote life sciences, biotech, medical device, pharmaceutical, and alliances across the biomedical industry in southern California and Asian countries.

Date/Time：Saturday, April 26th, 2014; 8:00 AM – 5:00 PM

Location：Crowne Plaza Hotel, 3131 Bristol Street, Costa Mesa, CA 92626

Registration: http://sabpa.org/web/OCLA/registration.html

• Registration questions can be directed to Huaina Li at huainal@yahoo.com
• General information about the SABPA OC/LA, please send an email to sabpa.ocla@gmail.com

Speakers

Larry A. Wheeler, Ph.D.（Keynote Speaker）
Sr. VP, Biological Sciences, Allergan, Inc.
"Challenges and opportunities in drug discovery"

Qiyi Luo（Keynote Speaker）
CTO and Cofounder, Shanghai Microport Medical Co., Ltd.
“Innovation in interventional medical devices for the treatment of heart diseases”

Wei Sun, Ph.D.
Albert Soffa Chair Professor
Department of Mechanical Engineering and Mechanics, Drexel University
“Bio–3D printing：Challenges and opportunities”

Yu-Chong Tai, Ph.D.
Prof. and Chair, Electrical Engineering, CalTech
“A new generation of micro implants for eye”

Terry Robins, Ph.D.
President, Molecular RxDx Strategies
“Personalized medicine：The future of diagnostic and pharmaceutical sciences”

Weian Zhao, Ph.D.
Asst. Prof., Pharmaceutical Sciences, UC Irvine
“Next generation diagnostics”

Raymond W. Brullo, D.P.M., FAPWCA
Compliance Officer, FDA, Los Angeles District Office
“Medical Devices, Drugs, Dietary Supplements Imported from China：Domestic Commerce Violations of the Food, Drug, and Cosmetic Act”

Agnes Juang, Ph.D., J.D.
Partner, Knobbe Martens Olson & Bear, LLP
“Avoiding patent infringement”

Panelists

Topic：“Medical devices in China”

Karen Liu
Partner, KaiWu Investment（a biomedical VC in China）

Chang Yu, Ph.D.
President, AnPac Bio-Medical Science Co., Ltd.（a cancer diagnostic company）

Liguo Qiang
President, Changzhou Yanling Electronics LLC（a medical device company）

Daozhi Liu, Ph.D.
President, Shanghai Pudong Medical Devices Professionals Association